En el glaucoma, el deterioro progresivo del nervio ptico es causado por la prdida de una poblacin neuronal especfica conocida como clulas ganglionares de la retina (CGR), de modo que la condicin ha sido clasificada como una enfermedad neurodegenerativa (85)
Designed for daily use, this lightweight cream supports visible improvements in hydration, elasticity, and overall skin vitality
The expression level of the ECM protein -1 type 1 collagen (Col11) was consistently decreased after treatment with the TP-10@CaP-CTP nanoparticles (Fig
Mayo Clinic (2024) Efficacy of GLP-1 receptor agonists on weight loss, BMI, and waist circumference for patients with obesity or overweight: A systematic review, meta-analysis, and meta-regression of 47 randomized controlled trials, Diabetes Care (2025) The efficacy and safety of danuglipron and orforglipron in patients with type 2 diabetes and obesity: a systematic review and meta-analysis, Frontiers in Endocrinology (2025) Efficacy and safety of danuglipron (PF-06882961) in adults with obesity: A randomized, placebo-controlled, dose-ranging phase 2b study, Diabetes, Obesity and Metabolism (2025) Exploring side effects and discontinuation reasons of glucagonlike-peptide-1 agonist (liraglutide, semaglutide) for weight loss among patients at King Abdulaziz University, Jeddah in 2021 to 2023, Journal of Clinical Medical Research (2025) FDA approves Novo Nordisks oral semaglutide for cardiovascular (CV) risk reduction in adults with type 2 diabetes who are at high risk, including those who have not had a prior CV event, Novo Nordisk (2025) FDAs concerns with unapproved GLP-1 drugs used for weight loss, FDA (2026) Innovative molecules and delivery technologies enabling the future of GLP-1-based therapies, Endocrine Reviews (2026) Novo Nordisk takes legal action against Hims & Hers to protect patients from unsafe, knock-off Wegovy and Ozempic, Novo Nordisk (2026) Novo Nordisks Wegovy pill, the first and only oral GLP-1 for weight loss in adults, now broadly available across America, Novo Nordisk (2026) Pfizers ultra-long-acting injectable GLP-1 RA shows robust and continued weight loss with monthly dosing in phase 2b trial, Pfizer (2026) Price guide, Novo Nordisk Real-world weight loss among patients initiating semaglutide 2.4 mg and enrolled in wegotogether, a digital self-support application, Advances in Therapy (2025) What to know about orforglipron: An investigational oral GLP-1, Eli Lilly and Company (2025) Real-world HbA1c changes among Type 2 diabetes mellitus patients initiating treatment with a 1.0 mg weekly dose of semaglutide for diabetes, Journal of Health Economics and Outcomes Research (2024) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
Product Specifications Application Ideas & Example Formulation Concepts Concept 1: Urban Anti-Pollution Radiance Serum GHK-Cu level : 0.05% Format : Aqueous gel serum Target pH : 5.5-6.0 Sensory profile : Light, fast-absorbing Co-actives : Hyaluronic acid, niacinamide, antioxidant complex Positioning : Daily defense against environmental stressors with anti-aging benefits Concept 2: Firming Eye Contour Gel GHK-Cu level : 0.02% Format : Light O/W emulsion Target pH : 5.5 Sensory profile : Non-greasy, quick absorption Co-actives : Caffeine, ceramides, peptide complex Positioning : Reduces visible signs of fatigue and aging around the delicate eye area Concept 3: Densifying Scalp Booster Spray GHK-Cu level : 0.1% Format : Leave-on scalp tonic spray Target pH : 5.0-6.0 Sensory profile : Lightweight, non-sticky Co-actives : Caffeine, rosemary extract, zinc PCA Positioning : Supports hair growth and scalp vitality for thinning hair Concept 4: Renewal Bi-Phase Serum GHK-Cu level : 0.05% Format : Bi-phase serum Target pH : 6.0 Sensory profile : Quick-absorbing, silky finish Co-actives : Panthenol, mild AHA blend Positioning : Nighttime skin renewal with gentle exfoliation Practical Tips for R&D and Scale-Up Processing Guidelines Addition timing : Incorporate pre-dissolved peptide in aqueous phase at cool-down (below 40C) Avoid : Prolonged high-shear mixing at elevated temperatures Validate : Hold times between manufacturing steps Quality Control Checklist Packaging Recommendations Airless pumps are preferred for oxygen-sensitive formulations Opaque containers minimize light exposure Consider an aluminum overwrap for additional protection Avoid excessive headspace in containers Stability Testing Protocol Ensure the GHK-Cu complex and overall system maintain integrity throughout the intended shelf life under these conditions
Studies indicate that individuals with lower B12 levels are more likely to be obese[2], even after accounting for factors like diet, lifestyle and medication use
